Carlos Cervera

[Carlos Cervera @carliocer]

The Impact of Colonization by Multi Drug Resistant Bacteria on Graft Survival, Risk of Infection, and Mortality in Recipients of Solid Organ Transplant: Systematic Review and Meta-analysis - Clinical Microbiology and Infection https://t.co/ToU663Y8BW

[Li Ka Shing Institute of Virology @LKSIoV]

We're excited to be supporting these amazing six undergrads in their journey of science and discovery! Read more about them https://t.co/o0PqHDmsQS @EdanFoley

[CIHR @CIHR_IRSC]

📣 The #GC announced the #NFRF recipients of the

➡️ 2022 Transformation stream
➡️ 2022 Exploration stream
➡️ Special call Research for Postpandemic Recovery results

Learn more: https://t.co/WQIZhfgMIm

[Li Ka Shing Institute of Virology @LKSIoV]

Check out LKSIoV member Dr. Carlos Cervera’s recent pub “Current landscape on phage therapy in infections: time to leave it behind for good?” https://t.co/i22IiCEMDy @carliocer @DoMResearch @UAlberta_DoM @UofAResearch

[Li Ka Shing Institute of Virology @LKSIoV]

Check out this pub of LKSIoV Members Dr Karen Doucette and Dr Carlos Cervera, "Efficacy and safety of antimicrobial stewardship prospective audit and feedback in patients hospitalised with COVID-19..." https://t.co/9ipj4xxdde
@doucette_ked1 @carliocer @UofA_ID @DoMResearch

[Carlos Cervera @carliocer]

@MaartenVHemelen @GermHunterMD @UofA_ID I think there are proof of concept papers targeting virulence factors but unsure if there is any experience in the clinical setting

[Carlos Cervera @carliocer]

@GermHunterMD @silentID3 @UofA_ID Agreed. But it may encourage people to read the full article

[The Lancet Infectious Diseases @TheLancetInfDis]

New research: Efficacy and safety of antimicrobial stewardship prospective audit and feedback in patients hospitalised with COVID-19 (COVASP): a pragmatic, cluster-randomised, non-inferiority trial
https://t.co/RYiB60Q40Q

[Laura Piddock 💙 @LauraPiddock]

Efficacy and safety of antimicrobial stewardship prospective audit and feedback in patients hospitalised with COVID-19 (COVASP): a pragmatic, cluster-randomised, non-inferiority trial https://t.co/urYKU2zYxS

[Pablo Guisado Vasco @PabloGVasco]

Estudio muy interesante por su diseño y tema que abordar. Todo lo que le pasa a un paciente con neumonía #COVID19 se debe a la infección viral, y las coinfecciones son muy poco frecuentes.
Un uso racional de antibióticos también es importante
Enlace aquí: https://t.co/c45kgn5uPn

[UofA Infectious Diseases @UofA_ID]

Congratulations ⁦@IDdocChen⁩ ⁦@HHoangMD⁩ ⁦⁦@carliocer⁩ et al: RCT of antimicrobial stewardship intervention in patients hospitalised w/COVID-19 in ⁦@TheLancetInfDis⁩ @UofA_ID⁩ ⁦⁦@UAlberta_DoM⁩ ⁦@UAlberta_FoMD⁩ https://t.co/D7b9cGRzx4

[Li Ka Shing Institute of Virology @LKSIoV]

Check out LKSIoV members Drs Karen Doucette & Carlos Cervera’s recent pub “Immune-based therapy for hospitalized patients with COVID-19 and risk of secondary infections: a systematic review & meta-analysis” https://t.co/v5zXDDv4Uk
@doucette_ked1 @UofA_ID @carliocer @DoMResearch

[Carlos Cervera @carliocer]

@GermHunterMD @jaguadog1 @doucette_ked1 @AshSonpar @belga_sara @AllisonMahMD @RazonableMD @oriolmitja @c_garciavidal @ichs2024 Thank you to Prof. Aguado, all authors and the support of @UAlberta_DoM @UofA_ID @LKSIoV

[Carlos Cervera @carliocer]

@GermHunterMD @jobadd @jaguadog1 @doucette_ked1 @AshSonpar @belga_sara @AllisonMahMD @RazonableMD @oriolmitja @c_garciavidal @ichs2024 Thank you @GermHunterMD . I think it can be very useful for ID (and other specialties) physicians. Hope people like it

[Carlos Cervera @carliocer]

@belga_sara @cburton791 @DocSaimaAslam @shahidh80523771 @RazonableMD Donation completed!

[Carlos Cervera @carliocer]

@nikkitheomd @UofA_ID @UAlberta_DoM thank you Nicole

[Carlos Cervera @carliocer]

@KatesOlivia @MichaelIsonMD @alfredopuing @AST_info @AjitLimaye2 Hi Olivia. @doucette_ked1 is the PI in our center and she is participating

[Carlos Cervera @carliocer]

@alfredopuing @MichaelIsonMD @AST_info @AjitLimaye2 @KatesOlivia @doucette_ked1 Agreed. Double lung Tx with mild disease at home in AB

[Alfredo Puing @alfredopuing]

@AST_info webinar on #COVID19 in SOT recipients - Seattle experience presented by @AjitLimaye2 - Cases presented many years after Tx with favorable outcomes - @KatesOlivia leading the efforts on collecting prospective multi-center data of COVID-19 in SOT - #TxID

[University of Alberta GI 🌲🇨🇦 @UAlbertaGI]

Congratulations to Dr. @JuanAbraldes of @UAlbertaGI
on receiving the @GiveToUHF „Champion of Care" award for his extraordinary work as a physician @Albertadoctors
@AHS_YEGZone @UAlberta_FoMD @UAlberta_DoM